Selitrectinib No Longer Available Phase N/A Trials for Solid Tumors Harboring NTRK Fusion

IndicationsStatusPurposePhase
No Longer AvailableNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03206931Expanded Access to Provide Selitrectinib for the Treatment of Cancers With a NTRK Gene Fusion